GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...

The lawsuits were filed in state courts nationwide, but the agreements don’t completely resolve Pfizer’s exposure to claims linking Zantac and cancer.

British pharmaceutical company GSK said on Wednesday that it has agreed to pay $2.3 billion to put an end to lawsuits in the United States alleging that its heartburn drug Zantac caused cancer.

Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation.

GSK has agreed to pay $2.2B to resolve approximately 80,000 lawsuits brought by users of Zantac who claimed the heartburn drug caused their cancer.

Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with ...

Google agreed to pay $1.4 billion to the State of Texas on Friday to settle two lawsuits accusing it of violating the privacy of state residents by tracking their locations and searches, as well ...

AstraZeneca has paid $425 million to settle roughly 11,000 personal injury claims over its heartburn drugs Nexium and Prilosec in the U.S.

GSK has reached agreements with 10 plaintiff firms to settle around 80,000 state court product liability cases related to its heartburn medication, Zantac, for $2.2 billion.